Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.
J Urol
; 190(5): 1686-91, 2013 Nov.
Article
en En
| MEDLINE
| ID: mdl-23665400
Palabras clave
BCG; BCG vaccine; CIS; CR; CSS; MIBC; NMIBC; NR; OS; PFS; PR; RFS; bacillus Calmette-Guérin; cancer specific survival; carcinoma in situ; complete response; gemcitabine; muscle invasive bladder cancer; no response; nonMIBC; overall survival; partial response; progression-free survival; recurrence-free survival; treatment failure; urinary bladder; urinary bladder neoplasms
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias de la Vejiga Urinaria
/
Desoxicitidina
/
Antimetabolitos Antineoplásicos
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Urol
Año:
2013
Tipo del documento:
Article